celecoxib has been researched along with piroxicam in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 14 (46.67) | 29.6817 |
| 2010's | 13 (43.33) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bertenshaw, SR; Burton, EG; Carter, JS; Cogburn, JN; Collins, PW; Docter, S; Graneto, MJ; Gregory, SA; Isakson, PC; Koboldt, CM; Lee, LF; Malecha, JW; Miyashiro, JM; Penning, TD; Perkins, WE; Rogers, RS; Rogier, DJ; Seibert, K; Talley, JJ; Veenhuizen, AW; Yu, SS; Zhang, YY | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Neha, K; Wakode, S | 1 |
| Browning, RA; Burgess, FW | 1 |
| Alarcón de la Lastra, C; Berenguer, B; Martín, MJ; Moreno, FJ | 1 |
| Büyükbayram, H; Ihsan Dokucu, A; Otcu, S; Ozdemir, E; Oztürk, H | 1 |
| Bakhle, YS; Chaves, CT; Ferreira-Alves, DL; Francischi, JN; Lima, AS; Moura, AC; Rocha, OA | 1 |
| Alarcón De La Lastra, C; Berenguer, B; Calero, MJ; Herrerias, JM; La Casa, C; Motilva, V; Pozo, D | 1 |
| Avila, MN; da Motta, PG; Duarte, ID; Francischi, JN; Tatsuo, MA; Veiga, AP | 1 |
| Ardicoglu, O; Erdogan, H; Fadillioglu, E; Gudul, H; Ozgocmen, S | 1 |
| Andriulli, A; Colaizzo, D; Dallapiccola, B; Di Mario, F; Franceschi, M; Grandone, E; Leandro, G; Niro, V; Pilotto, A; Scarcelli, C; Seripa, D | 1 |
| Dastis, SN; Geubel, AP; Lerut, J; Rahier, J | 1 |
| Chan, JY; Cheng, WT; Hsieh, PS; Kuo, CH; Liu, TT; Shyu, JF; Tsai, HC | 1 |
| Arai, I; Futaki, N; Harada, M; Hashimoto, Y; Honma, Y; Hoshi, K; Nakaike, S; Sugimoto, M | 1 |
| Chang, JK; Ho, ML; Li, CJ; Liao, HJ; Wang, CK; Wang, GJ | 1 |
| Kim, SH; Song, YC; Song, YS | 1 |
| Horn, TL; Johnson, WD; Lubet, RA; McCormick, DL; Phillips, JM; Steele, VE | 1 |
| Andreatini, R; Barbiero, J; Boschen, SL; Da Cunha, C; da Silva, LM; Lima, MM; Martynhak, BJ; Santiago, RM; Vital, MA; Werner, MF | 1 |
| Caimmi, D; Caimmi, SM; Demoly, P; Manca, E; Marseglia, GL | 1 |
| Ahmed, T; Ikram, MF; Syed, H; Yaqinuddin, A | 1 |
| Matteson, EL; Thongprayoon, C; Ungprasert, P | 1 |
| Choi, KH; Chung, MW; Lee, HJ; Park, JH; Um, SY | 1 |
| Blazejczyk, A; Dziegiel, P; Dzimira, S; Hildebrand, W; Krupa, A; Kutkowska, J; Obminska-Mrukowicz, B; Pawlak, A; Rapak, A; Strzadala, L; Wietrzyk, J; Ziolo, E | 1 |
| Agrawal, R; Assaiya, A; Banerjee, T; Jain, N; Kumar, A; Manivannan, E; Mufti, I; Parmar, HS; Tiwari, S | 1 |
| Crisafulli, S; Cutroneo, PM; Di Giovanni, V; Ferrajolo, C; Ficarra, V; Sottosanti, L; Spina, E; Trifirò, G; Verhamme, K | 1 |
3 review(s) available for celecoxib and piroxicam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Contemporary advances of cyclic molecules proposed for inflammation.
Topics: Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Humans; Inflammation; Molecular Structure; Structure-Activity Relationship | 2021 |
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cerebral Hemorrhage; Diclofenac; Humans; Ibuprofen; Incidence; Indomethacin; Lactones; Meloxicam; Naproxen; Observational Studies as Topic; Odds Ratio; Piroxicam; Proportional Hazards Models; Stroke; Sulfones; Thiazines; Thiazoles | 2016 |
1 trial(s) available for celecoxib and piroxicam
| Article | Year |
|---|---|
In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis.
Topics: Adult; Aged; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Male; Membrane Proteins; Middle Aged; Osteoarthritis, Knee; Oxidation-Reduction; Oxidative Stress; Piroxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reactive Oxygen Species; Sulfonamides | 2005 |
26 other study(ies) available for celecoxib and piroxicam
| Article | Year |
|---|---|
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Molecular Structure; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides | 1997 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Nonsteroidal anti-inflammatory drugs for perioperative pain control.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Humans; Ibuprofen; Indomethacin; Ketorolac; Lactones; Nabumetone; Naproxen; Pain, Postoperative; Piroxicam; Pyrazoles; Sulfonamides; Sulfones; Time Factors | 2001 |
Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dipyrone; Enzyme Inhibitors; Female; Gastric Mucosa; Isoenzymes; Male; Membrane Proteins; Omeprazole; Piroxicam; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Rats; Rats, Wistar; Stomach; Stomach Ulcer; Sulfonamides; Time Factors; Wound Healing | 2002 |
Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats.
Topics: Animals; Blood Urea Nitrogen; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diuresis; Isoenzymes; Kidney; Macrophages; Male; Natriuresis; Piroxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Ureteral Obstruction | 2002 |
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Topics: Animals; Carrageenan; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Hindlimb; Hyperalgesia; Indomethacin; Inflammation; Isoenzymes; Lactones; Male; Pain Threshold; Piroxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Sulfonamides; Sulfones | 2002 |
Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dipyrone; Female; Gastric Mucosa; Growth Substances; Hydrochloric Acid; Isoenzymes; Male; Membrane Proteins; Piroxicam; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides | 2004 |
Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Disease Models, Animal; Formaldehyde; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Piroxicam; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Tail | 2004 |
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Celecoxib; Cytochrome P-450 CYP2C9; Diclofenac; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Odds Ratio; Peptic Ulcer; Peptic Ulcer Hemorrhage; Piroxicam; Polymorphism, Single Nucleotide; Pyrazoles; Risk Assessment; Risk Factors; Sulfonamides | 2007 |
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Failure, Acute; Liver Transplantation; Middle Aged; Piroxicam; Pyrazoles; Sulfonamides | 2007 |
Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats.
Topics: Animals; Blood Glucose; Blood Pressure; Celecoxib; Cyclooxygenase Inhibitors; Fructose; Immunoblotting; Insulin; Insulin Resistance; Male; Piroxicam; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2008 |
The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Celecoxib; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Extremities; Fever; Freund's Adjuvant; Hyperalgesia; Hypothalamus; Inflammation; Male; Pain Measurement; Phenylpropionates; Piroxicam; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Wistar; Sulfonamides | 2009 |
Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts.
Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Dexamethasone; Diclofenac; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Indomethacin; Ketorolac; L-Lactate Dehydrogenase; Osteoblasts; Piroxicam; Propidium; Pyrazoles; RNA, Messenger; Sulfonamides; Thymidine | 2009 |
Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Topics: Antineoplastic Agents; Blotting, Western; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Piroxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Vulvar Neoplasms | 2009 |
Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.
Topics: Animals; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Gene Expression; Hydroxyurea; Lipoxygenase Inhibitors; Male; Mouth Neoplasms; Naproxen; Piroxicam; Pyrazoles; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Up-Regulation | 2010 |
Antidepressant-like effect of celecoxib piroxicam in rat models of depression.
Topics: Animals; Antidepressive Agents; Celecoxib; Depression; Disease Models, Animal; Exploratory Behavior; Food Deprivation; Glutathione; Lipid Peroxides; Male; Norepinephrine; Piroxicam; Pyrazoles; Rats; Rats, Wistar; Stress, Physiological; Sucrose; Sulfonamides; Superoxide Dismutase; Swimming; Time Factors; Water Deprivation | 2014 |
NSAID hypersensitivity in twins.
Topics: Adolescent; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Celecoxib; Child; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Drug Hypersensitivity; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Ibuprofen; Immunization; Immunoglobulin E; Piroxicam; Pyrazoles; Sulfonamides; Twins; Urticaria | 2014 |
Cyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice.
Topics: Aluminum Chloride; Aluminum Compounds; Animals; Celecoxib; Cerebral Cortex; Chlorides; Cognition; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hippocampus; Male; Maze Learning; Memory; Mice; Mice, Inbred BALB C; Neurotoxicity Syndromes; Piroxicam | 2015 |
(1)H-Nuclear magnetic resonance-based metabolic profiling of nonsteroidal anti-inflammatory drug-induced adverse effects in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Gastric Mucosa; Ibuprofen; Indomethacin; Least-Squares Analysis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolomics; Piroxicam; Rats; Rats, Sprague-Dawley | 2016 |
A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Celecoxib; Cell Line, Tumor; Dexamethasone; Dog Diseases; Dogs; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Imatinib Mesylate; Leukemia, B-Cell; Mice; Neoplasm Transplantation; Piroxicam | 2017 |
Inhibition of Aβ(1-42)Oligomerization, Fibrillization and Acetylcholinesterase Activity by Some Anti-Inflammatory Drugs: An in vitro Study.
Topics: Acetylcholinesterase; Amyloid; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Butylated Hydroxyanisole; Celecoxib; Dexamethasone; Diclofenac; Indomethacin; Methylene Blue; Nitric Oxide; Peptide Fragments; Piroxicam; Rivastigmine; Singlet Oxygen | 2017 |
Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database.
Topics: Adverse Drug Reaction Reporting Systems; Celecoxib; Drug-Related Side Effects and Adverse Reactions; Gabapentin; Humans; Lithium; Male; Piroxicam; Urinary Retention | 2022 |